Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Cardiac ketone body metabolism.

Abdul Kadir A. et al, (2020), Biochim Biophys Acta Mol Basis Dis, 1866

The role of triacylglycerol in cardiac energy provision.

Evans RD. and Hauton D., (2016), Biochim Biophys Acta, 1861, 1481 - 1491

Changes to both cardiac metabolism and performance accompany acute reductions in functional capillary supply.

Hauton D. et al, (2015), Biochim Biophys Acta, 1850, 681 - 690

Pharmacological inhibition of sarcolemmal fatty acid uptake provides a novel mechanism to improve metabolism in the Type 2 diabetic heart

Mansor LM. et al, (2015), DIABETIC MEDICINE, 32, 44 - 44

Varying degrees of ventricular unloading in the heterotopic rat heart transplant model demonstrated by magnetic resonance imaging.

Carr CA. et al, (2014), Int J Biomed Sci, 10, 223 - 228

Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy.

Niu Y. et al, (2013), J Physiol, 591, 5083 - 5093

Differential translocation of the fatty acid transporter, FAT/CD36, and the glucose transporter, GLUT4, coordinates changes in cardiac substrate metabolism during ischemia and reperfusion.

Heather LC. et al, (2013), Circ Heart Fail, 6, 1058 - 1066

Neonatal Antioxidant Treatment Prevents Impaired Cardiovascular Function at Adulthood Following Neonatal Glucocorticoid Therapy

Niu Y. et al, (2013), REPRODUCTIVE SCIENCES, 20, 133A - 134A

Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy

Niu Y. et al, (2013), Journal of Physiology

Myocardial substrate metabolism in heart disease

Evans R. and Clarke K., (2012), Frontiers in Bioscience, 4, 556 - 580

Myocardial substrate metabolism in heart disease.

Evans RD. and Clarke K., (2012), Front Biosci (Schol Ed), 4, 556 - 580

Energetic and Functional Abnormalities in Human Heart Failure are Associated with Increased Ventricular and Skeletal Muscle Mitochondrial Uncoupling Protein-3 Levels

Johnson AW. et al, (2011), CIRCULATION, 124

Mitochondrial uncoupling proteins and energetics in human heart and skeletal muscle

Johnson A. et al, (2011), ANAESTHESIA, 66, 69 - 69

Very-low-density lipoprotein: complex particles in cardiac energy metabolism

Evans RD. and Niu Y-G., (2011), Journal of Lipids, 2011

PPAR alpha is Essential for Cardiac Metabolic Adaptation to Chronic Hypoxia

Cole MA. et al, (2010), CIRCULATION, 122

Antioxidants Restore the Frank-Starling Mechanism in Hearts of Adult Rats Following Postnatal Glucocorticoid Therapy.

Niu Y. et al, (2010), REPRODUCTIVE SCIENCES, 17, 354A - 354A

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA IS ESSENTIAL FOR CARDIAC ADAPTATION TO CHRONIC HYPOXIA

Cole M. et al, (2010), HEART, 96

Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart.

Heather LC. et al, (2010), Endocrinology, 151, 422 - 431

Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.

Niu Y-G. and Evans RD., (2009), J Physiol, 587, 3301 - 3315

Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.

Niu Y-G. and Evans RD., (2008), Am J Physiol Endocrinol Metab, 295, E1106 - E1116

Load More

Include forthcoming?